Symbols / SINT Stock $2.47 -1.59% Sintx Technologies, Inc.

Healthcare • Medical Devices • United States • NCM
SINT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Eric K. Olson
Exch · Country NCM · United States
Market Cap 10.18M
Enterprise Value 9.29M
Income -17.08M
Sales 1.02M
FCF (ttm) -2.92M
Book/sh 0.74
Cash/sh 1.00
Employees 32
Insider 10d
IPO Feb 13, 2014
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -1.41
PEG
P/S 10.00
P/B 3.35
P/C
EV/EBITDA -0.91
EV/Sales 9.12
Quick Ratio 1.16
Current Ratio 1.51
Debt/Eq 110.92
LT Debt/Eq
EPS (ttm) -6.16
EPS next Y -1.75
EPS Growth
Revenue Growth -46.50%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2025-11-12
Earnings (prior) 2025-11-12
ROA -69.80%
ROE -3.04%
ROIC
Gross Margin 45.28%
Oper. Margin -7.88%
Profit Margin 0.00%
Shs Outstand 4.12M
Shs Float 3.24M
Insider Own 16.22%
Instit Own 7.10%
Short Float 5.38%
Short Ratio 5.98
Short Interest 199.91K
52W High 6.78
vs 52W High -63.57%
52W Low 2.22
vs 52W Low 11.26%
Beta 0.66
Impl. Vol.
Rel Volume 0.56
Avg Volume 32.90K
Volume 18.29K
Target (mean) $10.17
Tgt Median $10.00
Tgt Low $8.50
Tgt High $12.00
# Analysts 3
Recom Strong_buy
Prev Close $2.51
Price $2.47
Change -1.59%
About

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE). The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.47
Low
$8.50
High
$12.00
Mean
$10.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-13 init HC Wainwright & Co. — → Buy $10
2026-04-08 main Ascendiant Capital Buy → Buy $12
2025-12-08 main Ascendiant Capital Buy → Buy $16
2025-09-22 main Ascendiant Capital Buy → Buy $25
2025-05-30 main Ascendiant Capital Buy → Buy $28
2025-04-21 main Ascendiant Capital Buy → Buy $30
2024-02-05 down Maxim Group Buy → Hold
2023-04-03 main Maxim Group — → Buy $6
2023-02-15 main Maxim Group — → Buy $7
2023-01-20 main Maxim Group — → Buy $22
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-13 ELMORE ROBERT RYAN President 4,910 $2.88 $14,165
2026-03-02 LYONS CHRISTOPHER MICHAEL Director 8,292 $2.90 $24,092
2026-02-23 MOYES JAY M Director 1,000 $2.91 $2,910
2026-02-18 ANDERSON MARK LEWIS Director 3,000 $3.02 $9,060
2025-12-08 HONIGBLUM GREGG R. Chief Investment Officer 8,200 $4.24 $34,896
2025-12-05 HONIGBLUM GREGG R. Chief Investment Officer 53,867 $0.00 $0
2025-12-05 HONIGBLUM GREGG R. Chief Investment Officer 65,000 $3.77 $255,350
2025-11-07 HONIGBLUM GREGG R. Chief Investment Officer 10,000 $3.18 $31,900
2025-10-20 OLSON ERIC K Chief Executive Officer 5,800 $3.40 $19,720
2025-08-26 MOYES JAY M Director 3,000 $3.59 $10,756
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.73
-41.49%
1.25
+1.63%
1.23
+103.99%
0.60
Operating Revenue
0.73
-41.49%
1.25
+1.63%
1.23
+103.99%
0.60
Cost Of Revenue
0.56
-31.32%
0.81
+3.44%
0.78
+195.85%
0.27
Reconciled Cost Of Revenue
0.56
-31.32%
0.81
+3.44%
0.78
+195.85%
0.27
Gross Profit
0.17
-60.46%
0.43
-1.58%
0.44
+31.55%
0.34
Operating Expense
10.89
+14.99%
9.47
-31.36%
13.80
+18.24%
11.67
Research And Development
4.59
-11.81%
5.20
-40.31%
8.71
+35.09%
6.45
Selling General And Administration
6.44
+39.64%
4.61
-13.96%
5.36
+0.62%
5.33
Selling And Marketing Expense
0.24
-60.59%
0.61
-46.00%
1.14
-14.90%
1.34
General And Administrative Expense
6.20
+55.04%
4.00
-5.33%
4.22
+5.81%
3.99
Other Gand A
6.20
+55.04%
4.00
-5.33%
4.22
+5.81%
3.99
Other Operating Expenses
-0.13
+60.77%
-0.34
-24.63%
-0.27
-159.05%
-0.10
Total Expenses
11.45
+11.34%
10.28
-29.48%
14.58
+22.18%
11.94
Operating Income
-10.72
-18.62%
-9.04
+32.34%
-13.36
-17.85%
-11.34
Total Operating Income As Reported
-10.72
+23.68%
-14.05
-5.16%
-13.36
-17.85%
-11.34
EBITDA
-9.65
-0.41%
-9.61
-45.62%
-6.60
+40.32%
-11.06
Normalized EBITDA
-9.85
-31.23%
-7.51
+34.99%
-11.55
-15.87%
-9.97
Reconciled Depreciation
0.66
-52.17%
1.38
-16.48%
1.66
+72.07%
0.96
EBIT
-10.31
+6.21%
-10.99
-33.16%
-8.26
+31.32%
-12.02
Total Unusual Items
0.20
+109.65%
-2.10
-142.49%
4.95
+553.21%
-1.09
Total Unusual Items Excluding Goodwill
0.20
+109.65%
-2.10
-142.49%
4.95
+553.21%
-1.09
Special Income Charges
0.33
+106.50%
-5.03
-29676.47%
0.02
+1800.00%
-0.00
Other Special Charges
Restructuring And Mergern Acquisition
0.00
-100.00%
5.01
0.00
Net Income
-10.36
+5.99%
-11.02
-33.48%
-8.26
+31.40%
-12.04
Pretax Income
-10.36
+5.99%
-11.02
-33.48%
-8.26
+31.40%
-12.04
Net Non Operating Interest Income Expense
0.12
+57.69%
0.08
-41.35%
0.13
+2116.67%
0.01
Interest Expense Non Operating
0.05
+79.31%
0.03
+1350.00%
0.00
-88.24%
0.02
Net Interest Income
0.12
+57.69%
0.08
-41.35%
0.13
+2116.67%
0.01
Interest Expense
0.05
+79.31%
0.03
+1350.00%
0.00
-88.24%
0.02
Interest Income Non Operating
0.17
+63.55%
0.11
-20.74%
0.14
+486.96%
0.02
Interest Income
0.17
+63.55%
0.11
-20.74%
0.14
+486.96%
0.02
Other Income Expense
0.23
+111.34%
-2.06
-141.56%
4.97
+799.44%
-0.71
Other Non Operating Income Expenses
0.03
-20.51%
0.04
+129.41%
0.02
-95.55%
0.38
Gain On Sale Of Security
-0.12
-104.24%
2.92
-40.69%
4.93
+552.06%
-1.09
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-10.36
+5.99%
-11.02
-33.48%
-8.26
+31.40%
-12.04
Net Income From Continuing Operation Net Minority Interest
-10.36
+5.99%
-11.02
-33.48%
-8.26
+31.40%
-12.04
Net Income From Continuing And Discontinued Operation
-10.36
+5.99%
-11.02
-33.48%
-8.26
+31.40%
-12.04
Net Income Continuous Operations
-10.36
+5.99%
-11.02
-33.48%
-8.26
+31.40%
-12.04
Normalized Income
-10.57
-18.45%
-8.92
+32.46%
-13.21
-20.65%
-10.95
Net Income Common Stockholders
-17.08
-54.96%
-11.02
-33.06%
-8.29
+49.75%
-16.49
Otherunder Preferred Stock Dividend
4.45
Diluted EPS
-15.19
+97.57%
-624.47
+94.87%
-12,162.00
Basic EPS
-14.87
+96.65%
-443.47
+95.94%
-10,934.00
Basic Average Shares
0.74
+3867.72%
0.02
+1138.86%
0.00
Diluted Average Shares
0.74
+3318.63%
0.02
+1273.64%
0.00
Diluted NI Availto Com Stockholders
-17.08
-50.98%
-11.31
+16.83%
-13.61
+29.49%
-19.30
Average Dilution Earnings
0.00
+100.00%
-0.29
+94.53%
-5.32
-89.53%
-2.81
Gain On Sale Of PPE
0.33
+1821.05%
-0.02
-211.76%
0.02
+1800.00%
-0.00
Preferred Stock Dividends
6.72
0.03
-99.42%
4.45
Line Item Trend 2025-12-31 2023-12-31
Total Assets
9.51
-38.13%
15.37
Current Assets
5.65
+2.13%
5.53
Cash Cash Equivalents And Short Term Investments
4.14
+23.95%
3.34
Cash And Cash Equivalents
4.14
+23.95%
3.34
Receivables
0.18
-74.01%
0.69
Accounts Receivable
0.18
-74.01%
0.69
Gross Accounts Receivable
0.18
-76.17%
0.76
Allowance For Doubtful Accounts Receivable
-0.00
+96.67%
-0.07
Inventory
0.82
-7.09%
0.89
Raw Materials
Work In Process
Finished Goods
Prepaid Assets
Other Current Assets
0.51
-18.09%
0.62
Total Non Current Assets
3.86
-60.79%
9.83
Net PPE
2.93
-67.11%
8.92
Gross PPE
5.99
-52.54%
12.61
Accumulated Depreciation
-3.05
+17.33%
-3.69
Properties
0.00
0.00
Machinery Furniture Equipment
0.76
-14.77%
0.89
Other Properties
4.24
-56.24%
9.69
Leases
0.99
-51.38%
2.03
Goodwill And Other Intangible Assets
0.44
+2014.29%
0.02
Goodwill
0.30
Other Intangible Assets
0.14
+576.19%
0.02
Other Non Current Assets
0.48
-46.41%
0.89
Total Liabilities Net Minority Interest
6.58
-0.24%
6.59
Current Liabilities
3.73
+28.46%
2.91
Payables And Accrued Expenses
0.80
-60.59%
2.04
Payables
0.43
-45.93%
0.80
Accounts Payable
0.38
-39.94%
0.64
Other Payable
0.05
-69.33%
0.16
Current Accrued Expenses
0.37
-70.02%
1.24
Current Debt And Capital Lease Obligation
0.41
-27.42%
0.56
Current Debt
0.01
-84.78%
0.05
Other Current Borrowings
0.01
-84.78%
0.05
Current Capital Lease Obligation
0.40
-22.27%
0.51
Other Current Liabilities
2.52
+719.48%
0.31
Total Non Current Liabilities Net Minority Interest
2.84
-22.86%
3.69
Long Term Debt And Capital Lease Obligation
2.84
-22.86%
3.69
Long Term Debt
Long Term Capital Lease Obligation
2.84
-22.86%
3.69
Other Non Current Liabilities
Stockholders Equity
2.93
-66.61%
8.77
Common Stock Equity
2.93
-66.61%
8.77
Capital Stock
0.04
0.00
Common Stock
0.04
0.00
Preferred Stock
0.00
0.00
Share Issued
3.97
+14826.40%
0.03
Ordinary Shares Number
3.92
+14636.85%
0.03
Treasury Shares Number
0.05
0.00
Additional Paid In Capital
295.12
+5.60%
279.49
Retained Earnings
-292.10
-7.90%
-270.71
Treasury Stock
0.13
Total Equity Gross Minority Interest
2.93
-66.61%
8.77
Total Capitalization
2.93
-66.61%
8.77
Working Capital
1.92
-27.00%
2.63
Invested Capital
2.94
-66.70%
8.82
Total Debt
3.25
-23.46%
4.25
Capital Lease Obligations
3.24
-22.79%
4.20
Net Tangible Assets
2.48
-71.60%
8.75
Tangible Book Value
2.48
-71.60%
8.75
Notes Receivable
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.57
+0.82%
-8.64
+38.77%
-14.12
-37.53%
-10.26
Cash Flow From Continuing Operating Activities
-8.57
+0.82%
-8.64
+38.77%
-14.12
-37.53%
-10.26
Net Income From Continuing Operations
-10.36
+5.99%
-11.02
-33.48%
-8.26
+31.40%
-12.04
Depreciation Amortization Depletion
0.66
-52.17%
1.38
-16.48%
1.66
+72.07%
0.96
Depreciation
0.64
-53.37%
1.38
-16.53%
1.65
+72.44%
0.96
Amortization Cash Flow
0.02
+280.00%
0.01
+0.00%
0.01
+0.00%
0.01
Depreciation And Amortization
0.66
-52.17%
1.38
-16.48%
1.66
+72.07%
0.96
Amortization Of Intangibles
0.02
+280.00%
0.01
+0.00%
0.01
+0.00%
0.01
Other Non Cash Items
-0.37
+28.60%
-0.51
+17.89%
-0.63
-5.56%
-0.59
Stock Based Compensation
2.00
+2334.15%
0.08
-71.82%
0.29
-21.14%
0.37
Asset Impairment Charge
0.06
-98.67%
4.60
0.00
+100.00%
-0.01
Operating Gains Losses
-0.20
+94.13%
-3.46
+38.56%
-5.63
-615.29%
1.09
Gain Loss On Investment Securities
0.12
+103.57%
-3.48
+38.06%
-5.61
-614.21%
1.09
Gain Loss On Sale Of PPE
-0.35
-2055.56%
0.02
+205.88%
-0.02
-1800.00%
0.00
Change In Working Capital
-0.36
-224.48%
0.29
+118.44%
-1.55
-2720.00%
-0.06
Change In Receivables
-0.07
-114.08%
0.49
+216.67%
-0.42
-1515.38%
-0.03
Change In Inventory
-0.09
-218.06%
0.07
+114.85%
-0.48
-246.43%
-0.14
Change In Prepaid Assets
-0.05
-109.75%
0.48
+282.58%
-0.26
-2130.77%
0.01
Change In Payables And Accrued Expense
-0.20
+73.54%
-0.76
-6200.00%
-0.01
-105.31%
0.23
Change In Other Current Liabilities
0.04
+2350.00%
-0.00
+99.46%
-0.37
-189.06%
-0.13
Investing Cash Flow
0.91
+570.62%
-0.19
+61.28%
-0.50
+54.50%
-1.10
Cash Flow From Continuing Investing Activities
0.91
+570.62%
-0.19
+61.28%
-0.50
+54.50%
-1.10
Net PPE Purchase And Sale
0.91
+236.27%
-0.67
-33.73%
-0.50
+64.32%
-1.40
Purchase Of PPE
-0.19
+72.61%
-0.69
-30.19%
-0.53
+62.28%
-1.41
Sale Of PPE
1.10
+5410.00%
0.02
-31.03%
0.03
+2800.00%
0.00
Capital Expenditure
-0.19
+72.61%
-0.69
-30.19%
-0.53
+62.28%
-1.41
Net Business Purchase And Sale
0.00
-100.00%
0.30
Gain Loss On Sale Of Business
0.03
0.00
Net Other Investing Changes
0.48
Financing Cash Flow
8.20
-9.83%
9.09
-22.35%
11.71
+251.05%
3.34
Cash Flow From Continuing Financing Activities
8.20
-9.81%
9.09
-22.36%
11.71
+251.05%
3.34
Net Issuance Payments Of Debt
-0.21
+40.97%
-0.35
-206.14%
-0.11
+77.60%
-0.51
Issuance Of Debt
0.00
Repayment Of Debt
-0.21
+40.97%
-0.35
-206.14%
-0.11
+77.60%
-0.51
Long Term Debt Issuance
0.00
Long Term Debt Payments
-0.21
+40.97%
-0.35
-206.14%
-0.11
+77.60%
-0.51
Net Long Term Debt Issuance
-0.21
+40.97%
-0.35
-206.14%
-0.11
+77.60%
-0.51
Net Common Stock Issuance
0.20
0.00
Common Stock Payments
-0.13
0.00
Repurchase Of Capital Stock
-0.13
0.00
+100.00%
-0.00
0.00
Proceeds From Stock Option Exercised
8.21
+35.14%
6.08
+17.35%
5.18
0.00
Net Other Financing Charges
3.37
-49.35%
6.65
Changes In Cash
0.54
+110.08%
0.26
+108.88%
-2.90
+63.81%
-8.03
Beginning Cash Position
3.60
+7.72%
3.34
-46.52%
6.25
-56.25%
14.27
End Cash Position
4.14
+15.06%
3.60
+7.72%
3.34
-46.52%
6.25
Free Cash Flow
-8.76
+6.13%
-9.33
+36.28%
-14.64
-25.51%
-11.67
Interest Paid Supplemental Data
0.05
+79.31%
0.03
+38.10%
0.02
+2000.00%
0.00
Common Stock Issuance
0.33
0.00
Issuance Of Capital Stock
0.33
0.00
0.00
-100.00%
3.85
Net Preferred Stock Issuance
0.00
+100.00%
-0.00
-100.05%
3.85
Preferred Stock Issuance
0.00
-100.00%
3.85
Preferred Stock Payments
0.00
+100.00%
-0.00
0.00
Sale Of Business
0.00
-100.00%
0.30
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category